First Report of Parkinsonism Associated With Indoximod, an Immune-Modulating Agent

by Mark Floyd, Badi El Osta, Shou-Ching Tang
Published 2016-11-01

Unfortunate Accident or Blessing in Disguise? Dramatic Response to Incidental Intrathoracic Delivery of Anti-HER2 Regimen

by Khurram Tariq, Ryan Keen, Karen Draper, Shou-Ching Tang
Published 2017-03-01

Metastatic Breast Cancer Presenting As Orbital Mass: A Case Report With Literature Review

by Rizwan Shaikh, Khurram Tariq, Suash Sharma, Shou-Ching Tang
Published 2017-03-01

Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity

by Ibrahim Sadek, Mark Keaton, Nita J. Maihle, Shou-Ching Tang
Published 2017-09-01

The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

by Kai Li, Lei Ma, Ye Sun, Xiang Li, Hong Ren, Shou-Ching Tang, Xin Sun
Published 2021-09-01

Modulation of BAG-1 Expression Alters the Sensitivity of Breast Cancer Cells to Tamoxifen

by Hong Liu, Su Lu, Lin Gu, Yongchang Gao, Tong Wang, Jing Zhao, Jianyu Rao, Jun Chen, Xishan Hao, Shou-Ching Tang
Published 2014-02-01

Cloning and functional analysis of FLJ20420: a novel transcription factor for the BAG-1 promoter.

by Hongyu Liu, Ying Li, Yongwen Li, Baoxin Liu, Heng Wu, Jing Wang, Yuli Wang, Min Wang, Shou-Ching Tang, Qinghua Zhou, Jun Chen
Published 2012-01-01

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

by Xiaolin Yu, Sharad Ghamande, Haitao Liu, Lu Xue, Shuhua Zhao, Wenxi Tan, Lijing Zhao, Shou-Ching Tang, Daqing Wu, Hasan Korkaya, Nita J. Maihle, Hong Yan Liu
Published 2018-03-01